Ventura, Baby Boy R.
HRN: 22-23-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/21/2022
11/28/2022
IVT
40 Mg
24 Hrs
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes